[HTML][HTML] Potassium channels in behavioral brain disorders. Molecular mechanisms and therapeutic potential: a narrative review.

KA Alam, P Svalastoga, A Martinez, JC Glennon… - Neuroscience & …, 2023 - Elsevier
Abstract Potassium channels (K+-channels) selectively control the passive flow of potassium
ions across biological membranes and thereby also regulate membrane excitability. Genetic …

Epilepsy syndromes in the first year of life and usefulness of genetic testing for precision therapy

A Bayat, M Bayat, G Rubboli, RS Møller - Genes, 2021 - mdpi.com
The high pace of gene discovery has resulted in thrilling advances in the field of epilepsy
genetics. Clinical testing with comprehensive gene panels, exomes, or genomes are now …

KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum

CM Bonardi, HO Heyne, M Fiannacca, MP Fitzgerald… - Brain, 2021 - academic.oup.com
Variants in KCNT1, encoding a sodium-gated potassium channel (subfamily T member 1),
have been associated with a spectrum of epilepsies and neurodevelopmental disorders …

Potassium channelopathies associated with epilepsy-related syndromes and directions for therapeutic intervention

VK Gribkoff, RJ Winquist - Biochemical Pharmacology, 2023 - Elsevier
A number of mutations to members of several CNS potassium (K) channel families have
been identified which result in rare forms of neonatal onset epilepsy, or syndromes of which …

Early-onset developmental and epileptic encephalopathies of infancy: an overview of the genetic basis and clinical features

N Morrison-Levy, F Borlot, P Jain, R Whitney - Pediatric neurology, 2021 - Elsevier
Our current knowledge of genetically determined forms of epilepsy has shortened the
diagnostic pathway usually experienced by the families of infants diagnosed with early …

Design, synthesis, and biological evaluation of a novel series of 1, 2, 4-oxadiazole inhibitors of SLACK potassium channels: Identification of in vitro tool VU0935685

MQ Alshaima'a, BD Spitznagel, Y Du… - Bioorganic & Medicinal …, 2023 - Elsevier
Malignant migrating partial seizure of infancy (MMPSI) is a devastating and
pharmacoresistant form of infantile epilepsy. MMPSI has been linked to multiple gain-of …

Precision therapy with quinidine of KCNT1‐related epileptic disorders: A systematic review

D Xu, S Chen, J Yang, X Wang… - British Journal of …, 2022 - Wiley Online Library
Aims Despite numerous studies on quinidine therapies for epilepsies associated with
KCNT1 gene mutations, there is no consensus on its clinical utility. Thus, we reviewed …

Efficacy of anti‐seizure medications and alternative therapies (ketogenic diet, CBD, and quinidine) in KCNT1‐related epilepsy: A systematic review

M Gras, D Bearden, J West, R Nabbout - Epilepsia Open, 2024 - Wiley Online Library
Objective KCNT1‐related epilepsies encompass three main phenotypes:(i) epilepsy of
infancy with migrating focal seizures (EIMFS),(ii) autosomal dominant or sporadic sleep …

Targeting KNa1. 1 channels in KCNT1-associated epilepsy

BA Cole, SJ Clapcote, SP Muench, JD Lippiat - Trends in Pharmacological …, 2021 - cell.com
Gain-of-function (GOF) pathogenic variants of KCNT1, the gene encoding the largest known
potassium channel subunit, K Na 1.1, are associated with developmental and epileptic …

Recent advances in gene therapy for neurodevelopmental disorders with epilepsy

TJ Turner, C Zourray, S Schorge… - Journal of …, 2021 - Wiley Online Library
Neurodevelopmental disorders can be caused by mutations in neuronal genes fundamental
to brain development. These disorders have severe symptoms ranging from intellectually …